KONDRONOVA Capsules, # 30

Kondronova caps.

No. 30

Name ENG

KONDROnova

Clinical and pharmacological group

A drug that regulates metabolism in cartilage tissue

ATX code

Other drugs for the treatment of diseases of the musculoskeletal system

Dosage

250mg + 200mg

Structure

1 caps .: chondroitin sulfate 200 mg, glucosamine hydrochloride 250 mg

Indications

Osteoarthritis of the peripheral joints and joints of the spine.

Storage conditions and periods

In a dry, dark place, at a temperature not exceeding 30 degrees.

Expiration date: 2 years

INN / Active ingredient

Chondroitin sulfate + glucosamine

Contraindications

Hypersensitivity to drug components.

Pregnancy and lactation.

Childhood.

Carefully:

Diabetes.

Bronchial asthma.

Bleeding tendency.

Thrombophlebitis.

Specifications

Scope of the drug

Musculoskeletal system

Release form

Capsules

Manufacturer country

India

Package quantity, pcs

thirty

Scope of application

Rheumatology

Minimum age from

18 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Panacea Biotec

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Tissue repair stimulant

Dosage form

Capsules

Packaging

Box

Expiration date in days

730

The target audience

Adult

Dosage (volume) of the substance in the preparation

chondroitin sulfate 200 mg

glucosamine hydrochloride 250 mg

Package weight, g

35

Category

:

Joints

,

Treatment of diseases of the musculoskeletal system

,

Synovial fluid

,

Bone metabolism

Mode of application

:

Orally.

Adults take 2 capsules 2-3 times a day.

After 60 days of therapy, the dose should be gradually reduced depending on the needs of the individual patient.

Course of treatment: 2-3 months (the duration of treatment is determined by the doctor).

A second course of treatment is possible only after consulting a doctor.

Anatomical and therapeutic characteristics

:

M09AX Other drugs for the treatment of diseases of the musculoskeletal system